Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$539M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$365M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$361M |
| 4 |
Charter Communications
CHTR
|
+$349M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.31B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$283M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$257M |
| 4 |
State Street SPDR S&P Global Natural Resources ETF
GNR
|
+$230M |
| 5 |
VanEck Oil Services ETF
OIH
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.94% |
| 2 | Healthcare | 5.53% |
| 3 | Financials | 5.03% |
| 4 | Consumer Discretionary | 4.6% |
| 5 | Industrials | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGEN
1926
Agenus
AGEN
$276M
| $2.6M | ﹤0.01% |
64,762
+13,321
| +26% | +$679K |
|
|
KDNY
1927
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.6M | ﹤0.01% |
132,007
+87,710
| +198% | +$1.76M |
|
1928
Axalta
AXTA
$7.45B
| $2.59M | ﹤0.01% |
123,209
-7,871
| -6% | -$193K |
|
1929
CALL
Prudential Financial
PRU
$42.6B
| $2.59M | ﹤0.01% |
+30,200
| New | +$2.91M |
|
|
GXDW
1930
Global X Funds Global X Dorsey Wright Thematic ETF
GXDW
$5.64M
| $2.59M | ﹤0.01% |
100,000
| – | – |
|
|
SGFY
1931
DELISTED
Signify Health, Inc.
SGFY
| $2.59M | ﹤0.01% |
88,811
-69,994
| -44% | -$1.61M |
|
|
CBL
1932
CBL Properties
CBL
$1.84B
| $2.59M | ﹤0.01% |
101,015
-3,035
| -3% | -$86.7K |
|
1933
Virgin Galactic
SPCE
$315M
| $2.58M | ﹤0.01% |
27,430
-11,800
| -30% | -$1.51M |
|
1934
Cullen/Frost Bankers
CFR
$10.5B
| $2.58M | ﹤0.01% |
19,528
+1,943
| +11% | +$255K |
|
1935
iShares Latin America 40 ETF
ILF
$3.73B
| $2.58M | ﹤0.01% |
108,877
-46,951
| -30% | -$1.12M |
|
|
ZING
1936
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
| $2.58M | ﹤0.01% |
256,729
+150,000
| +141% | +$1.48M |
|
1937
CALL
Williams Companies
WMB
$85.8B
| $2.58M | ﹤0.01% |
90,000
| – | – |
|
|
1938
PUT
Williams Companies
WMB
$85.8B
| $2.58M | ﹤0.01% |
90,000
| – | – |
|
1939
CALL
UBS Group
UBS
$170B
| $2.57M | ﹤0.01% |
175,000
| – | – |
|
1940
The Ensign Group
ENSG
$10.6B
| $2.57M | ﹤0.01% |
32,362
+2,625
| +9% | +$217K |
|
1941
Cheesecake Factory
CAKE
$5.03B
| $2.57M | ﹤0.01% |
87,716
-21,148
| -19% | -$642K |
|
1942
CALL
Novavax
NVAX
$1.21B
| $2.57M | ﹤0.01% |
141,000
-125,800
| -47% | -$5.45M |
|
1943
WEX
WEX
$6.42B
| $2.57M | ﹤0.01% |
20,223
+238
| +1% | +$37.4K |
|
1944
Arcturus Therapeutics
ARCT
$165M
| $2.57M | ﹤0.01% |
173,126
+46,252
| +36% | +$776K |
|
1945
Credit Acceptance
CACC
$5.82B
| $2.56M | ﹤0.01% |
5,846
-1,274
| -18% | -$672K |
|
|
CITE
1946
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
| $2.56M | ﹤0.01% |
253,701
+3,700
| +1% | +$37.2K |
|
1947
CALL
Skyworks Solutions
SWKS
$9.2B
| $2.56M | ﹤0.01% |
30,000
| – | – |
|
1948
Carvana
CVNA
$47.5B
| $2.55M | ﹤0.01% |
629,210
-3,052,000
| -83% | -$19.9M |
|
1949
PUT
BioMarin Pharmaceuticals
BMRN
$11.9B
| $2.54M | ﹤0.01% |
30,000
-10,000
| -25% | -$890K |
|
|
STET
1950
DELISTED
ST Energy Transition I Ltd.
STET
| $2.54M | ﹤0.01% |
253,127
| – | – |
|
Similar funds
Citigroup's Q3 2022 Portfolio in Review
As of Q3 2022, Citigroup held 6,714 positions worth $140B, up 4% from $134B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup deployed $13.5B of net new capital in Q3 2022, opening 321 new positions and adding to 2,151 existing holdings. Its largest new stake was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.31B trimmed.
- Citigroup's largest Q3 2022 buy was Invesco S&P SmallCap Information Technology ETF: 420,000 shares worth $15.5M.
- Citigroup added most to Lowe's Companies in Q3 2022, an estimated $539M increase.
- Citigroup's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.31B.
- Citigroup fully exited GCP Applied Technologies Inc. in Q3 2022, selling an estimated $18.7M.
- Citigroup's ten largest holdings make up 30% of its $140B portfolio in Q3 2022.
- Citigroup opened 321 new positions and closed 759 in Q3 2022.
- Citigroup's portfolio value rose 4% quarter-over-quarter to $140B.
Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.